These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 3061383

  • 21. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
    Etesse-Carsenti H, Garraffo R, Bernard E, de Salvador F, Pradier C, Durant J, Mondain V, Drugeon HB, Dellamonica P.
    Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
    [Abstract] [Full Text] [Related]

  • 22. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
    Acar N, Diri MC, Türkyilmaz FR.
    Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
    [Abstract] [Full Text] [Related]

  • 23. Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum beta-lactamases and strains with extended-spectrum activity of the chromosomal beta-lactamase.
    Decré D, Burghoffer B, Gautier V, Petit JC, Arlet G.
    J Antimicrob Chemother; 2004 Nov; 54(5):881-8. PubMed ID: 15472005
    [Abstract] [Full Text] [Related]

  • 24. [Sensitivity to clavulanic acid of Escherichia coli isolated at the Henri Mondor hospital in 1986 according to phenotypes of beta-lactam antibiotic resistance].
    Soussy CJ, Le Van Thoi J, Duval J.
    Pathol Biol (Paris); 1988 May; 36(5):442-5. PubMed ID: 3043340
    [Abstract] [Full Text] [Related]

  • 25. [Detection of hyperproduction of chromosomal beta-lactamase in strains of Escherichia coli, Enterobacter cloacae and Pseudomonas aeruginosa].
    Roy C, Tirado M, Segura C, Esteva C, Teruel D.
    Enferm Infecc Microbiol Clin; 1989 May; 7(6):301-6. PubMed ID: 2518766
    [Abstract] [Full Text] [Related]

  • 26. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ, Amyes SG.
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [Abstract] [Full Text] [Related]

  • 27. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
    Paniagua GL, Monroy E, García O, Vaca S.
    Rev Latinoam Microbiol; 1998 Jun; 40(3-4):128-34. PubMed ID: 10932741
    [Abstract] [Full Text] [Related]

  • 28. Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
    Ponte C, Gracia M, Giménez MJ, Aguilar L, Maín CM, Carpintero Y, Huelves L, Carcas A, del Prado G, Soriano F.
    Clin Ther; 2005 Jul; 27(7):1043-9. PubMed ID: 16154483
    [Abstract] [Full Text] [Related]

  • 29. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE, Gurwith MJ.
    Clin Pharm; 1984 Jul; 3(6):591-9. PubMed ID: 6391783
    [Abstract] [Full Text] [Related]

  • 30. Beta-lactamase evaluation of the amoxycillin-clavulanate association.
    Novelli A, Reali EF, Fallani S, Periti P.
    Drugs Exp Clin Res; 1989 Jul; 15(4):151-4. PubMed ID: 2505995
    [Abstract] [Full Text] [Related]

  • 31. Clinical isolates of Escherichia coli producing multiple TEM mutants resistant to beta-lactamase inhibitors.
    Sirot D, Chanal C, Henquell C, Labia R, Sirot J, Cluzel R.
    J Antimicrob Chemother; 1994 Jun; 33(6):1117-26. PubMed ID: 7928805
    [Abstract] [Full Text] [Related]

  • 32. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
    Birgy A, Delecourt M, Geslain G, Desselas E, Caseris M, Magnan M, Mariani-Kurkdjian P, Bidet P, Bonacorsi S.
    J Antimicrob Chemother; 2017 Jul 01; 72(7):1911-1914. PubMed ID: 28369441
    [Abstract] [Full Text] [Related]

  • 33. [Measure by turbidimetry and bactericidal effect of the speed of action of clavulanic acid, amoxicillin and their combinations on a Haemophilus influenzae producer of beta-lactamase].
    Yourassowsky E, Van der Linden MP, Lismont MJ, Crokaert F, Glupczynski Y.
    Pathol Biol (Paris); 1987 May 01; 35(5):526-30. PubMed ID: 3302856
    [Abstract] [Full Text] [Related]

  • 34. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
    Wootton M, Walsh TR, Macfarlane L, Howe RA.
    J Antimicrob Chemother; 2010 Jan 01; 65(1):79-81. PubMed ID: 19915068
    [Abstract] [Full Text] [Related]

  • 35. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M, Pous-Miralles G, Romera-Sastre G, Panisello-Bertomeu JM, Jardí-Baiges AM, Zarazoga-López J.
    Enferm Infecc Microbiol Clin; 1997 Nov 01; 15(9):477-81. PubMed ID: 9527373
    [Abstract] [Full Text] [Related]

  • 36. [False sensitivity of Enterococcus faecium to amoxicillin-clavulanic acid with the MicroScan system].
    Joyanes P, Pascual A, Suárez AI, Martínez-Martínez L.
    Enferm Infecc Microbiol Clin; 1995 Feb 01; 13(2):96-8. PubMed ID: 7711133
    [Abstract] [Full Text] [Related]

  • 37. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD, Le P, Church DL, Gregson DB, Laupland KB.
    Int J Antimicrob Agents; 2008 Oct 01; 32(4):333-8. PubMed ID: 18701262
    [Abstract] [Full Text] [Related]

  • 38. In vitro activity, beta-lactamase stability and PBP affinity of RU 51,746-2, the active metabolite of the new orally absorbed cephalosporin ester, RU 51807.
    Boaretti M, Lleó MM, Canepari P.
    J Chemother; 1991 Jan 01; 3 Suppl 1():57-61. PubMed ID: 12041787
    [Abstract] [Full Text] [Related]

  • 39. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
    Grimm H.
    Arzneimittelforschung; 1987 Oct 01; 37(10):1116-9. PubMed ID: 3501722
    [Abstract] [Full Text] [Related]

  • 40. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM, De Renzi G, Tullio V, Paizis G, Carlone NA.
    Drugs Exp Clin Res; 1996 Oct 01; 22(1):9-15. PubMed ID: 8839632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.